Sugentech Inc. (KOSDAQ: 253840)

Market Cap	109.47B
Revenue (ttm)	9.71B
Net Income (ttm)	-12.11B
Shares Out	15.29M
EPS (ttm)	-859.60
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	330,285
Average Volume	4,205,967
Open	7,320.00
Previous Close	7,410.00
Day's Range	7,290.00 - 7,500.00
52-Week Range	4,700.00 - 11,500.00
Beta	-3.08
RSI	52.44
Earnings Date	Feb 28, 2025

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2011
• Employees: 145
• Stock Exchange: KOSDAQ
• Ticker Symbol: 253840